Calculated based on number of publications stored in Pure and citations from Scopus
1992 …2022

Research activity per year

If you made any changes in Pure these will be visible here soon.

Network

Koji Kawakami

  • Kyoto University
  • United States Food and Drug Administration
  • Department of Pharmacoepidemiology
  • School of Medicine and Public Health
  • Lab. of Molecular Tumor Biology
  • Ctr. for Biologics Eval./Research

External person

Shiro Hinotsu

  • Kyoto University
  • University of Tsukuba
  • Okayama University
  • Japan Wilms Tumor Study Group (JWiTS)
  • Japanese Urological Association
  • UroVysion Clinical Evaluation Group
  • Center for Innovative Clinical Medicine
  • Department of Pharmacoepidemiology
  • Center for Innovative Clinical Medicine
  • Working Group of the Renal Pelvic and Ureteral Cancer Registration Committee
  • Graduate School of Comprehensive Human Sciences
  • School of Medicine and Public Health
  • Registration Committee of the Japanese Urological Association
  • Working Group of the Upper Urinary Tract Urothelial Carcinoma (UTUC)
  • Department of Biostatistics and Clinical Epidemiology
  • Sapporo Medical University
  • Japan Wilms Tumor Study Group (JWiTS)
  • Gunma University
  • Department of Urology
  • Working Group of the UTUC Registration Committee of the Japanese Urological Association
  • Working Group of the Renal Pelvic and Ureteral Cancer
  • Cancer Registration Committee of the Japanese Urological Association
  • Cancer Registration Committee of the Japanese Urological Association
  • Working Group of the Renal Pelvic and Ureteral Cancer

External person

Shinya Kimura

  • Japan Medical Data Center Co., Ltd.
  • JMDC Inc.

External person

Junko Sato

  • Pharmaceuticals and Medical Devices Agency

External person

Tatsuro Ishizaki

  • Tokyo Metropolitan Institute of Gerontology
  • Kyoto University
  • Department of Health Informatics
  • Human Care Research Team
  • Tokyo Metropolitan Geriatric Hospital

External person

Tsuyoshi Sasaki

  • Department of Child Psychiatry
  • Chiba University

External person

Toshiki Fukasawa

  • Division of Drug Development & Regulatory Science

External person

Toshihiko Satoh

  • Tokyo Women's Medical University
  • Kitasato University
  • Aoyama Gakuin University
  • University of Occupational and Environmental Health, Japan
  • Dept. of Hygiene and Public Health
  • School of Social Informatics
  • Kitasato Clinical Research Center
  • Department of Preventive Medicine and Public Health

External person

M. Tohda

  • Hokkaido University

External person

Sachiko Nakaoka

  • Kyoto University
  • Department of Health Informatics

External person

Shiro Tanaka

  • Kyoto University
  • Department of Pharmacoepidemiology

External person

Masanori Taketsuna

  • Asia Pacific Statistical Science
  • Eli Lilly Japan K.K., Medical Science, Medicines Development Unit Japan
  • Lilly Research Laboratories Development Center of Excellence Asia Pacific

External person

Natsumi Shibata

  • Division of Drug Development & Regulatory Science

External person

Yasuyuki Nomura

  • Nihon University
  • Hokkaido University
  • University of Toyama
  • Department of Otorhinolaryngology-Head and Neck Surgery
  • Department of Neuroscience

External person

Naobumi Hamadate

  • Hamadate Science Office

External person

Takeo Nakayama

  • Kyoto University
  • Department of Health Informatics
  • Department of Medical System Informatics
  • Kanto
  • Department of Health Informatics
  • University Graduate School of Medicine

External person

Mayuko Kuroda

  • Division of Drug Development & Regulatory Science

External person

Takumi Hirata

  • Foundation for Biomedical Research and Innovation
  • Center for Supercentenarian Medical Research
  • Tohoku University
  • Department of Preventive Medicine and Epidemiology
  • Cohort Study Team
  • Foundation for Biomedical Research and Innovation at Kobe
  • Foundation for Biomedical Research and Innovation
  • Foundation for Biomedical Research and Innovation
  • Tohoku Medical Megabank Organization
  • Division of Personalized Prevention and Epidemiology
  • Pro-Cluster Kobe, Foundation for Biomedical Research and Innovation
  • Hokkaido University
  • Foundation for Biomedical Research and Innovation
  • Foundation for Biomedical Research and Innovation at Kobe

External person

Akimitsu Miyauchi

  • Miyauchi Medical Center
  • Surveillance and Epidemiology
  • Eli Lilly Japan K.K
  • Eli Lilly

External person

Kousei Yoh

  • Hyogo College of Medicine
  • Aino Gakuin College
  • Department of Orthopedic Surgery
  • Faculty of Health Science
  • Aino University

External person

Hyerim Park

  • The University of Tokyo
  • Laboratory of Drug Lifetime Management

External person

Etsuro Hamaya

  • Medical Science
  • Eli Lilly Japan K.K., Medical Science, Medicines Development Unit Japan
  • Lilly Research Laboratories Development Center of Excellence Japan

External person

Shinji Kosugi

  • Kyoto University
  • Genetic Counselling and Clinical Research Unit
  • Clinical Research Coordinator Course

External person

Takeshi Hirakawa

  • Nippon Boehringer Ingelheim Co., Ltd.

External person

Fumiyo Kita

  • Kyoto University
  • Department of Pharmacoepidemiology

External person

Masaki Nakamura

  • Medical Data Vision
  • Business Development Department
  • Medical Data Vision Co. Ltd

External person

Yasufumi Sawada

  • Kyushu University
  • The University of Tokyo
  • Fukuoka University
  • Kyushu Clinical Pharmacology Research Clinic
  • Tokyo University of Pharmacy and Life Science
  • Laboratory of Drug Informatics
  • Graduate School of Interdisciplinary Information Studies
  • Department of Medico-Pharmaceutical Sciences
  • Department of Pharmaceutics
  • Interfaculty Initiative in Information Studies
  • Faculty of Pharmaceutical Sciences
  • Department of Biopharmaceutics
  • 1Department of Pharmaceutics
  • Graduate School of Interdisciplinary Information Studies
  • Department of Drug Metabolism and Molecular Toxicology
  • Department of Reproduction and Gynecology
  • Graduate School of Interdisciplinary Information Studies
  • Department of Astronomy
  • Faculty of Pharmaceutical Sciences
  • Department of Hospital Pharmacy
  • Department of Clinical Pharmacokinetics
  • Tottori University
  • Laboratory of Drug Informatics
  • Graduate School of Pharmaceutical Sciences
  • NPO Drug Lifetime Management Center
  • Drug Lifetime Management Center
  • Laboratory of Drug Lifetime Management
  • Laboratory of Neurobiophysics
  • Strategic Investigation on Comprehensive Cancer Network
  • Grad. Sch. Pharmaceutical Sci., K.
  • Kyushu University

External person

Hanae Ueyama

  • Kyoto University
  • Department of Pharmacoepidemiology

External person

Kiyoshi Tanaka

  • Kyoto Women's University

External person

Shunya Ikeda

  • International University of Health and Welfare
  • Showa University
  • Office of Health Economics
  • Department of Pharmaceutical Sciences
  • School of Pharmacy

External person

Kenji Matsui

  • University of Toyama
  • Shiga University of Medical Science
  • Niigata Prefectural Kashiwazaki and Nagaoka Public Health Center
  • National Cerebral and Cardiovascular Center
  • Department of Research Ethics and Bioethics
  • Department of Health Science
  • Takashima Cohort
  • National Cerebral and Cardiovascular Center
  • National Cancer Center Japan

External person

Satoshi Teramukai

  • Kyoto University
  • Kanazawa University
  • Kyoto Prefectural University of Medicine
  • Translational Research Center
  • Department of Biostatistics
  • Translational Research Center
  • Pro-Cluster Kobe, Foundation for Biomedical Research and Innovation
  • Translational Research Informatics Center
  • Foundation for Biomedical Research and Innovation at Kobe

External person

Yoshihiro Wakazono

  • Kyoto-Katsura Hospital
  • Kyoto Katsura Hospital

External person

Eriko Ogura

  • Shionogi & Co., Ltd.

External person

Nancy Dreyer

  • IQVIA Inc.

External person

Chihiro Suematsu

  • Kyoto University
  • Graduate School of Management

External person

Akiko Miki

  • The University of Tokyo
  • Kyushu University
  • Graduate School of Pharmaceutical Sciences
  • Laboratory of Drug Informatics
  • Department of Medico-Pharmaceutical Sciences
  • Laboratory of Drug Informatics
  • NPO Drug Lifetime Management Center
  • Laboratory of Neurobiophysics
  • Strategic Investigation on Comprehensive Cancer Network
  • Laboratory of Drug Lifetime Management

External person

Kaoru Morikawa

  • National Institute of Health Sciences Tokyo
  • Division of Safety Information on Drug

External person

Hideaki Sowa

  • Medical Science
  • Lilly Research Laboratories Development Center of Excellence Japan

External person

Daisuke Kuroki

  • Nippon Boehringer Ingelheim Co., Ltd.

External person

Ryohei Sato

  • Division of Drug Development & Regulatory Science

External person

S. Kato

  • Tokai University
  • Department of Pediatrics
  • Dept. Cell Transplant./Regen. Med.
  • Department of Cell Transplantation and Regeneration Medicine
  • Department of Cell Transplantation
  • Department of Pediatrics
  • Research Center for Regenerative Medicine and Cancer Stem Cell
  • Department of Cell Transplantation and Regenerative Medicine
  • Japan Marrow Donor Program
  • Res. Grp. for Stem Cell Transplant.

External person

Shimon Tashiro

  • National Cancer Center Japan
  • Center for Public Health Sciences
  • Tohoku University

External person

Shunro Kai

  • Hyogo College of Medicine
  • Department of Transfusion Medicine

External person

Masaya Koshizaka

  • Chiba University
  • Department of Diabetes Metabolism and Endocrinology
  • Department of Clinical Cell Biology
  • Clinical Research Center
  • Department of Diabetes
  • Department of Endocrinology
  • Department of Diabetes

External person

Nobutaka Kikuchi

  • Surveillance and Epidemiology
  • Eli Lilly Japan K.K
  • Eli Lilly

External person

Hiroki Satoh

  • The University of Tokyo

External person

Norin Kameyama

  • Division of Drug Development & Regulatory Science

External person

Tatsutoshi Nakahata

  • Kyoto University
  • The University of Tokyo
  • Department of Pediatrics
  • Department of Clinical Oncology
  • Department of Clinical Application
  • Center for iPS Cell Research and Application (CiRA)
  • Department of Pharmacoepidemiology

External person

Shihori Furuhata

  • Division of Drug Development & Regulatory Science

External person

Kunihiko Takahashi

  • Department of Biostatistics
  • Nagoya University
  • Department of Biostatistics
  • Tokyo Medical and Dental University

External person

Tsuneo A. Takahashi

  • The University of Tokyo
  • Kyoto University
  • New York Blood Center

External person

Manami Yoshida

  • Shionogi & Co., Ltd.

External person

Mayumi Yamada

  • Surveillance and Epidemiology
  • Eli Lilly Japan K.K
  • Eli Lilly

External person

Takashi Kawamura

  • Kyoto University
  • Department of Preventive Service

External person

Mitsutoshi Yamamoto

  • Takamatsu Neurology Clinic

External person

Takeru Shiroiwa

  • National Institute for Public Health
  • Department of Health and Welfare Services, National Institute for Public Health

External person

Yoko M. Nakao

  • Department of Preventive Cardiology, National Cerebral and Cardiovascular Center
  • National Cerebral and Cardiovascular Center
  • National Cerebral and Cardiovascular Center
  • Department of Preventive Medicine and Epidemiologic Informatics
  • National Cerebral and Cardiovascular Center
  • National Cerebral and Cardiovascular Center Research Institute
  • Department of Preventive Medicine and Epidemiology Informatics
  • National Cerebral and Cardiovascular Center
  • Department of Preventive Medicine and Epidemiologic Informatics
  • Department of Preventive Medicine and Epidemiologic Informatics
  • Department of Preventive Cardiology
  • Division of Evidence-Based Medicine and Risk Analysis
  • Department of Preventive Medicine and Epidemiology Informatics National Cerebral and Cardiovascular Center Suita Japan
  • Kyoto University
  • National Cerebral and Cardiovascular Center
  • Departments of Preventive Cardiology
  • Preventive Medicine and Epidemiology Informatics

External person

Kaori Ohta

  • National Institutes for Quantum and Radiological Science and Technology
  • Research Center for Charged Particle Therapy

External person

Hiroki Sugimori

  • Daito Bunka University
  • Tokyo Women's Medical University
  • Department of Preventive Medicine
  • Daito Bunka University

External person

Naoichiro Yukawa

  • Kyoto University
  • Department of Rheumatology and Clinical Immunology
  • Department of Rheumatology and Clinical Immunology

External person

T. Kadowaki

  • The University of Tokyo
  • Department of Diabetes and Metabolic Diseases
  • Department of Global Health Policy
  • Department of Diabetes and Metabolic Diseases
  • Department of Metabolic Diseases
  • Department of Metabolic Diseases
  • Translational Systems Biology and Medicine Initiative
  • Graduate School of Medicine
  • Northwestern University
  • Japan Science and Technology Agency
  • Teikyo University
  • National Institute of Health and Nutrition Tokyo
  • Teikyo University
  • Toranomon Hospital

External person

Setsuko Taneichi

  • The University of Tokyo
  • Graduate School of Education
  • Department of Clinical Research and Informatics
  • Office for Mental Health Support
  • National Center for Global Health and Medicine
  • Division of Clinical Epidemiology
  • Office for Mental Health Support

External person

Tetsuro Shimakawa

  • Rakuwakai Otowa Hospital
  • Rakuwakai Otowa Hospital

External person

Tohru Yorifuji

  • Osaka City General Hospital
  • Kyoto University
  • Department of Pediatric Endocrinology and Metabolism
  • Division of Pediatric Endocrinology and Metabolism
  • Turner Syndrome Research Collaboration

External person

Hideaki Sawai

  • Kyoto University
  • Hyogo College of Medicine
  • Genetic Counselling and Clinical Research Unit
  • Department of Clinical Genetics
  • Departments of Obstetrics and Gynecology

External person

Asahi Tanaka

  • Division of Drug Development & Regulatory Science

External person

Shogo Miyazawa

  • Shionogi & Co., Ltd.

External person

Fumito Yoshiki

  • Surveillance and Epidemiology
  • Eli Lilly Japan K.K
  • Eli Lilly

External person

Tsuneyo Mimori

  • Kyoto University
  • Tokyo Metropolitan Police Hospital
  • Ministry of Health, Labour and Welfare
  • Eijyu General Hospital
  • University Graduate School of Medicine
  • Tokyo Metropolitan Ohtsuka Hospital
  • Department of Rheumatology and Clinical Immunology
  • Department of Rheumatology and Clinical Immunology
  • Division of Rheumatic Diseases
  • Department of Clinical Immunology
  • Departmet of Internal Medicine
  • Research Team for Autoimmune Diseases
  • Research Team for Autoimmune Diseases
  • Yale University
  • Section of Infectious Diseases
  • Tokyo Metropolitan Ohtsuka Hospital
  • University Graduate School of Medicine
  • Division of Pulmonary Medicine
  • Department of Rheumatology and Clinical Immunology
  • Ministry of Health
  • Research Team for Autoimmune Diseases
  • Ijinkai Takeda General Hospital
  • Ijinkai Takeda General Hospital
  • Japan Ministry of Health, Labour and Welfare

External person

Hideki Maeda

  • Astellas Pharma Inc.
  • Clinical Development II Department
  • Meiji Pharmaceutical University

External person

Kenji Kishida

  • Takeda General Hospital
  • Takeda General Hospital
  • Takeda General Hospital

External person

Naoko Iino

  • National Center for Global Health and Medicine
  • Department of Clinical Research and Informatics

External person

Eiko Yamauchi

  • Yamauchi Clinic

External person

Rei Maeda

  • Global Patient Safety Japan

External person

Shinichi Nishiuma

  • Global Patient Safety Japan

External person

Takanori Yamamoto

  • Medical Science
  • Lilly Research Laboratories Development Center of Excellence Japan

External person

Masakazu Fujiwara

  • Shionogi & Co., Ltd.

External person

Shimon Tashiroc

  • National Cancer Center Japan
  • Office for Bioethics

External person

Akiko Miki

  • The University of Tokyo

External person

Atsushi Ogawa

  • Kyoto University
  • Department of Pharmacoepidemiology

External person

Yuji Nakamura

  • Medical Data Vision
  • Medical Data Vision Co. Ltd

External person

Yuka Murakami

  • Division of Drug Development & Regulatory Science

External person

Hideaki Masuda

  • Dentsu Public Relations Inc
  • Healthcare Communications

External person

Hideyuki Maki

  • Sompo Care Inc.

External person

Maika Asawa

  • Division of Drug Development & Regulatory Science

External person

Tomohisa Horibe

  • Kyoto University
  • Department of Pharmacoepidemiology

External person

Minoko Takanashi

  • Japanese Red Cross Medical Center
  • Tokyo Metropolitan Red Cross Blood Center
  • Blood Service Headquarters
  • Japan Marrow Donor Program
  • Blood Service Headquarters
  • Technical Department
  • Japanese Red Cross Society
  • The Metro Tokyo Red Cross Cord Blood Bank
  • The Japanese Red Cross Tokyo Blood Center
  • Japanese Red Cross Tokyo Metropolitan Blood Center
  • Japanese Red Cross Tokyo Blood Center

External person

Tomohiro Hatta

  • Division of Drug Development & Regulatory Science

External person

Takuji Komeda

  • Shionogi & Co., Ltd.

External person

Akiko Shibata

  • Kyoto University
  • Department of Pharmacoepidemiology

External person

Toshiyuki Sumida

  • Nippon Boehringer Ingelheim Co., Ltd.

External person

Takeshi Yamashita

  • Cardiovascular Institute
  • Cardiovascular Institute
  • Cardiovascular Institute
  • The Cardiovascular Institute
  • Department of Cardiovascular Medicine
  • The Cardiovascular Institute
  • The Cardiovascular Institute

External person

Risa Fukuda

  • Department of Dermatology
  • Tokyo Dental College

External person

Shota Hamada

  • Department of Pharmacoepidemiology
  • Kyoto University
  • Association for Health Economics Research and Social Insurance and Welfare
  • University of Tsukuba
  • Association for Health Economics Research and Social Insurance and Welfare

External person

Masahiro Yasaka

  • National Hospital Organization, Japan

External person

Kanae Hara

  • Shionogi & Co., Ltd.

External person

Kentaro Takeda

  • Astellas Pharma Inc.

External person

Sayako Matsui

  • Kyoto University
  • Department of Pharmacoepidemiology

External person

Tsutomu Matsuda

  • Yamagata University
  • Department of Pharmaceutical and Medical Device Regulatory Science

External person

Nobuyoshi Takabayashi

  • Kyoto University
  • Department of Pharmacoepidemiology

External person

Takeomi Inoue

  • ArBlast Co., Ltd.
  • Kobe International Business Center

External person

Naoto Yamakawa

  • Division of Drug Development & Regulatory Science

External person

Keisuke Ito

  • Division of Drug Development & Regulatory Science

External person

Shintaro Sengoku

  • Kyoto University
  • Institute for Integrated Cell-Material Sciences

External person

Yusuke Narita

  • Division of Drug Development & Regulatory Science

External person

Hiroshi Sasaki

  • Sasaki Pediatric Clinic

External person

Yuko Doi

  • Ain Pharmaciez Inc.

External person

Yasuhisa Ono

  • Nippon Boehringer Ingelheim Co., Ltd.

External person

S. Hashimoto

  • Kyoto University
  • Fukushima Medical University

External person

Kosuke Ishida

  • Nippon Boehringer Ingelheim Co., Ltd.

External person

Noriko Tada

  • Kyoto University
  • Department of Pharmacoepidemiology
  • Genetic Counselling and Clinical Research Unit

External person

Kosuke Iwasaki

  • Milliman Inc.

External person

Michiko Yamamoto

  • Showa Pharmaceutical University
  • Education Centre for Clinical Pharmacy Practice

External person

Kiminari Ito

  • Foundation for Biomedical Research and Innovation at Kobe

External person

Tomoaki Tanaka

  • ArBlast Co., Ltd.

External person

Yoichi Nakanishi

  • Kyushu University
  • Osaka University
  • Department of Clinical Medicine
  • Research Institute for Diseases of the Chest
  • Department of General Thoracic Surgery
  • Research Institute for Disease of the Chest
  • Department of Clinical Medicine
  • Kyushu University

External person

Gen Kobashi

  • National Institutes for Quantum and Radiological Science and Technology
  • Dokkyo Medical University
  • Department of Public Health
  • Departmentof Planning and Management

External person

Louise Parmenter

  • Real-World Insights
  • IQVIA Inc.

External person

Hiroki Satoh

  • The University of Tokyo
  • Kyushu University
  • Graduate School of Pharmaceutical Sciences
  • Department of Medico-Pharmaceutical Sciences
  • Laboratory of Drug Informatics
  • Laboratory of Drug Informatics
  • NPO Drug Lifetime Management Center
  • Laboratory of Drug Lifetime Management
  • Interfaculty Initiative in Information Studies
  • Laboratory of Neurobiophysics
  • Strategic Investigation on Comprehensive Cancer Network

External person

Chiduru Kobayashi

  • Shionogi & Co., Ltd.

External person

Hirotaka Katada

  • Kyoto University
  • Department of Pharmacoepidemiology

External person

Eisei Oda

  • Medical TOUKEI Corporation
  • Medical Toukei Co., Ltd
  • Medical Tokei Co., Ltd
  • AC Medical Inc.

External person

Nobuaki Sarai

  • Nippon Boehringer Ingelheim Co., Ltd.

External person

Yosuke Fujii

  • Ain Pharmaciez Inc.

External person

Koji Chiba

  • Division of Drug Development & Regulatory Science
  • Yokohama University of Pharmacy
  • Department of Drug Discovery and Development
  • Johnson & Johnson

External person

Osamu Takizawa

  • Kyoto University
  • Department of Pharmacoepidemiology

External person

Taira Maekawa

  • Kyoto University
  • The University of Tokyo
  • Department of Transfusion Medicine and Cell Therapy
  • Division of Transfusion Medicine

External person

Yoshie Onishi

  • Kyoto University
  • Department of Pharmacoepidemiology

External person

Masaru Arai

  • Kraft Inc.

External person

Akira Kitagawa

  • Kobe International Business Center
  • ArBlast Co., Ltd.

External person

Noriko Iikuni

  • Eli Lilly
  • Tokyo Women's Medical University
  • Lilly Bio-Medicine
  • Institute of Rheumatology
  • Department of Internal Medicine
  • Pfizer

External person

Ying Liu

  • Global Patient Safety Japan

External person

Masato Takeuchi

  • Kyoto University
  • Department of Pharmacoepidemiology

External person

Kohei Asai

  • Sompo Care Inc.

External person

Yukihiro Koretsune

  • Osaka National Hospital

External person